An early quantitative resuscitation strategy improves outcome in critically ill patients. The hemodynamic endpoints of such a strategy have been a topic of debate in the literature. This review focuses on the use of lactate as a marker for risk stratification, lactate clearance as a hemodynamic endpoint, and its use compared to mixed venous oxygenation as a resuscitation goal.
INTRODUCTION
Historically, hemodynamics refers to a set of parameters that define cardiovascular function and blood flow through the circulation. Classically, these are markers of the macrocirculation, such as cardiac output, mean arterial pressure, mixed venous oxygen saturation, and indices of preload, such as central venous pressure. In the setting of critical illness, improving pathological values is likely beneficial and are common targets for the practicing clinician. However, there is increasing evidence suggesting traditional hemodynamic parameters are unreliable [1] , and the ability to apply a set of hemodynamic norms across individual patients with differing physiology can be inappropriate [2] . Also, normalization of hemodynamics often leaves a significant proportion of patients with ongoing tissue hypoperfusion [3] . Given this, there is an increasing trend to monitor and normalize the surrogates of cellular perfusion as resuscitation targets. In this fashion, lactate clearance has been proposed as a hemodynamic resuscitation target in the critically ill. As a marker of tissue perfusion, it is influenced not only by the macrocirculation, but also by the microcirculation (network of arterioles, capillaries, and venules), as well as mitochondrial function. This review will focus on the use of lactate as a hemodynamic marker and target for resuscitation in the critically ill.
BACKGROUND AND HISTORY
The ability to characterize and detect circulatory failure and tissue hypoperfusion has been in evolution for over a century [4] . This has historically hinged on clinical symptoms and physical exam findings, both of which are marred by a lack of sensitivity to detect organ dysfunction. In 1918, Cannon, describing metabolic acidosis, stated 'there is a relationship between blood flow, and hence tissue perfusion and blood pH values' [5] . Lactate was first described after isolation from sour milk in 1780 [5] . The first reports of lactate in sepsis were in 1843 by German physician-chemist, Johann-Joseph Scherer (a friend of Rudolph Virchow) when he described the detection of high lactate levels from an autopsy heart puncture in a 23-year-old women who died from puerperal septic shock, likely due to Streptococcus pyogenes [6] . The clinical syndrome of lactic acidosis was specifically characterized in 1961 and correlated with poor outcome [7, 8] . The association of lactate accumulation and oxygen debt during shock states has been described for decades [9] . Throughout the years, there has been continued interest in refining clinically important values, resuscitation triggers, and response to therapy.
NORMAL LACTATE METABOLISM
Lactate is the metabolic end-product of anaerobic glycolysis. In conditions of low flow or cellular hypoxia, pyruvate cannot enter the mitochondria and is preferentially reduced to lactate, causing arterial lactate concentrations to increase [5, 10] . This is an adaptive process to generate energy, but comes at the expense of worsening acidosis. Lactate is produced in all tissues, but the greatest producers are skeletal muscle, brain, intestine, and red blood cells. During critical illness, increasing lactate production arises from the lungs, as well as white blood cells and splanchnic organs. The daily production of lactate is around 1300 mmol/day, and the concentration of arterial lactate is a reflection of net production and clearance, and is generally around 2 mmol/l. Metabolism and clearance of lactate is primarily via the liver and kidneys, and dysfunction of these organs has been associated with varying levels of reduced clearance [5, 10] .
Lactic acidosis occurs whenever production exceeds utilization and clearance. Type A lactic acidosis describes an inadequate oxygen delivery and consumption match and the presence of anaerobic glycolysis, and type B lactic acidosis describes hyperlactatemia in the absence of anaerobic glycolysis (secondary to altered clearance, malignancy, or drugs, for example) [5] . Medications that have been associated with hyperlactatemia include nucleoside reverse transcriptase inhibitors, epinephrine, metformin, methanol, cyanide and ethylene glycol. It is also possible that the proinflammatory state of sepsis can produce a stress hyperlactatemia in the absence of overt tissue hypoxia. Type A lactic acidosis is likely the most common cause of elevated lactate in the critically ill patient with overt hemodynamic perturbations; however, both types likely exist together to some degree in a significant number of patients. For lactate levels to be normal and aerobic metabolism to work, the body needs an intact macrocirculation (and therefore organ perfusion), microcirculation, and mitochondrial function. The clinician must keep this in mind, as an elevated lactate forecasts a poor prognosis, but exactly why it is elevated and where the lactate is coming from is often difficult to elucidate. As one might expect, lactic acidosis, not hyperlactatemia itself, is the primary predictor of in-hospital mortality as has been demonstrated in septic patients presenting to the emergency department [11] .
LACTATE FOR RISK STRATIFICATION
Lactate has been studied as a marker of critical illness severity for decades [9] . The pathophysiology of lactate production, clearance, and kinetics are not always straightforward, but hyperlactatemia is typically present with delivery-dependent oxygen consumption. However, there is no precise critical level of oxygen delivery or central venous oxygen saturation that is associated with hyperlactatemia. This is thought to be related to the importance of regional, not just global, oxygen delivery in tissue perfusion. Even after normalization of the macrocirculation, a significant number of patients remain in 'cryptic' or 'occult' shock, secondary to persistent cellular hypoperfusion [3, [12] [13] [14] [15] . For this reason, a low threshold for checking lactate levels should be maintained, as the correlation between lactate elevation and surrogate markers of hypoperfusion, such as physical exam, and anion gap, is low [16] .
KEY POINTS
In the setting of critical illness, lactate elevation, even to a mild degree, is associated with worse outcome.
Lactate levels should be checked to identify patients with occult tissue hypoperfusion and for risk stratification.
Lactate clearance is associated with improved outcomes in the setting of early resuscitation.
The use of lactate clearance may be as beneficial as mixed venous oxygenation in select patient populations and should be viewed as a complementary resuscitation target.
The exact level pointing to a worse outcome can be debated, depending on the patient cohort and trial quoted. However, general themes in the literature exist: the higher the lactate elevation, the higher the mortality tends to be; even mild elevations of lactate identify patient groups at higher risk for worse outcome. This data is consistent over several patient populations, to include severe sepsis and septic shock [17] , cardiac arrest [18] , and trauma [19, 20] . In fact, in the setting of severe sepsis, a mild elevation (2-3.9 mmol/l) in lactate is associated with mortality, independent of shock or organ failure [21 & ]. These data strongly suggest that any elevation in lactate in the patient with sepsis should raise concern for increased mortality, but the accepted threshold for initiation of formal early goal-directed therapy, treatment protocols, and care bundles has traditionally been 4 mmol/l [17, 22, 23] .
LACTATE CLEARANCE AS A HEMODYNAMIC ENDPOINT
Similar to all monitoring devices or biomarkers, unless linked with a therapy that improves outcome, merely checking or monitoring lactate levels will not improve outcome. The aim of any therapy should be the reversal of global tissue hypoxia, and a decrease in lactate values to normal levels can serve as a surrogate in this regard. The data on lactate clearance are also fairly consistent: compared with nonclearers of lactate, patients who clear elevated lactate levels have improved outcomes and the slower that lactate clearance is achieved, the worse the outcome [19, 24, 25 && ,26 && ,27,28]. In surgical ICU patients, persistent hyperlactatemia was 100% predictive of mortality in a single-center study [27] . In patients achieving lactate clearance within 24 h, mortality fell to 3.9%. In elective cardiac surgical patients, a protocol aimed at lactate clearance was associated with decreased hospital stay [29] . In critically ill septic patients, an early and more pronounced lactate clearance is associated with reduced mortality [3, 24] . Also in septic patients, a multicenter trial showed patients with lactate clearance (!10% decrease in lactate from initial measurement) had a 41% decrease in absolute mortality compared to nonclearers of lactate [26 && ]. In another multicenter trial from a mixed ICU population, serial lactate monitoring, along with a protocolized treatment algorithm aimed at reversing both macrocirculatory and microcirculatory dysfunction, resulted in a decrease in mortality, organ failure, and ICU days [25 && ]. The measurement of lactate serves three purposes: to establish the diagnosis of severe sepsis (infection plus elevated lactate); if !4 mmol/l may trigger early goal-directed therapy; and if elevated may provide the baseline for targeting resuscitation to lactate clearance. It is clear from the literature that elevated lactate should be a cause for concern and serial lactate monitoring, with aim for clearance, should be a target for resuscitation in the critically ill.
What is less clear is what the therapeutic plan should be in patients with a persistently elevated lactate, as the literature is less robust in certain arenas. As another therapeutic potential, lactateguided resuscitation may afford the clinician the ability to know when to cease aggressive resuscitation and to decrease potentially harmful interventions. 
LACTATE CLEARANCE VERSUS MIXED VENOUS OXYGENATION AS A RESUSCITATION GOAL
Quantitative resuscitation involves a protocoldriven delivery of care targeting predefined physiological goals. Data support an early quantitative resuscitation strategy to improve outcome in the critically ill [36 & ]. Although the optimal targets are of debate and the data suggest a lack of consensus, what is clear is that some sort of quantitative resuscitation strategy should be used [36 & ,37] . Despite robust clinical data showing improved outcome associated with serial lactate monitoring and lactate-guided resuscitation, current guidelines do not include this as a therapeutic endpoint [23] . This topic has been the focus of intense debate recently [38] . Each parameter has limitations, as well as certain attractions physiologically. Each parameter has the capability for obtaining values through bedside measurement [continual measurement for mixed venous oxygenation (S v O 2 ) and point-of-care measurement for lactate]. Both values can also be measured by sending blood to the laboratory.
Classic teaching is that S v O 2 and lactate are concordant variables: as oxygen consumption becomes delivery dependent, S v O 2 will decrease, the patient will reach their anaerobic threshold, and lactate levels will increase. However, in a multicenter trial of severe sepsis patients receiving quantitative resuscitation, 79% of patients with persistently elevated lactate values had central venous oxygen saturation (S cv O 2 ) values !70% [26 && ]. Lactate clearance was a stronger predictor of inhospital mortality when compared to optimization of S cv O 2 , and S cv O 2 values of !70% could not exclude lactate nonclearance. The authors concluded that 'serial lactate measurement may provide unique and important information on resuscitation effectiveness' [26 && ]. Furthermore, a significant percentage of patients with sepsis present with venous hyperoxia (S cv O 2 >89%), which may be a worse prognostic indicator than venous hypoxia, and for which there are currently no therapeutic options [39 && ]. In another multicenter trial involving severe sepsis and septic shock patients, protocolized resuscitation targeting !10% lactate clearance versus S cv O 2 values !70% produced similar in-hospital mortality (17% lactate clearance group versus 23% S cv O 2 group), using a noninferiority clinical trial design [40 && ]. However, many knowledgeable individuals in this research area, despite the results of this study, would take little comfort in knowing their resuscitation efforts had lowered an initially very high lactate by only 10%.
In the setting of a quantitative resuscitation strategy, enough data do not exist to strongly recommend targeting lactate clearance over S cv O 2 or vice versa. Enough data do exist to recommend a quantitative resuscitation strategy, targeting either lactate clearance, S cv O 2 !70%, and perhaps a combination [36 & ]. These parameters should be viewed not as rivals, but as complementary to resuscitation goals. The wise clinician will titrate resuscitative efforts to individual patient response and cease 
CONCLUSION
The resuscitation of the critically ill patient should be aimed at reversing early tissue hypoxia, not at strictly achieving predefined static hemodynamic parameters. Although hyperlactatemia can be complex in cause, robust data associate its presence with increased morbidity and mortality across a wide array of critically ill patients. Similarly, lactate values have been shown to be accurate for risk stratification, and lactate clearance is associated with improved outcome. A quantitative resuscitation strategy is recommended to reverse global tissue hypoxia in the early stages of shock. The clinician should choose to follow lactate clearance and S cv O 2 based on individual patient characteristics and response to therapy. When global tissue hypoxia is reversed, aggressive resuscitation should be stopped, thereby preventing unnecessary interventions.
